Recent 8-K filings for SRTS

• June 5, 2026, 4:08 PM ET debt materiality 0.60 neutral item 1.01item 9.01 ◈ Material Agreements

  Sensus Healthcare enters into $15M revolving credit facility with City National Bank of Florida

  $15M revolving credit facility; initial $2M available secured by $2.23M cash collateral and blanket asset lien.

• May 7, 2026, 7:59 PM ET earnings materiality 0.75 negative item 2.02item 9.01 ◈ Earnings Releases

  Sensus Healthcare Q1 revenue drops to $3.4M; cash $18.3M, no debt

  Revenue of $3.4M, down 59% vs $8.3M in Q1 2025; no sales to historically largest customer (15 units in prior year).

• February 12, 2026, 6:59 PM ET earnings materiality 0.70 negative item 2.02item 9.01

  Sensus Healthcare Q4 2025 revenue $4.9M, net loss $3.2M; CMS code boost effective Jan 2026

  Q4 revenue $4.9M, down from $13.1M YoY; net loss $3.2M ($0.19/sh) vs net income $1.5M ($0.09/sh) in Q4 2024.

• November 6, 2025, 6:59 PM ET earnings materiality 0.75 negative item 2.02item 9.01

  Sensus Q3 2025: Revenue down 21.6% to $6.9M; net loss of $0.9M vs profit of $1.2M a year ago

  Net loss of $0.9M ($0.06 per share) vs net income of $1.2M ($0.07 diluted) in Q3 2024.

• August 7, 2025, 7:59 PM ET earnings materiality 0.75 negative item 2.02item 9.01

  Sensus Healthcare Q2 2025 revenue $7.3M, net loss $1.0M; ships 19 SRT systems, FDA volume up 27% sequentially

  Revenue $7.3M vs $9.2M YoY; net loss $1.0M ($0.06/sh) vs net income $1.6M ($0.10/sh) in Q2 2024.

• May 15, 2025, 7:59 PM ET earnings materiality 0.70 negative item 2.02item 9.01

  Sensus Healthcare Q1 revenues $8.3M, net loss $2.6M vs. net income $2.3M year ago; forecasts profitability rest of year

  Revenue $8.3M, down 22% YoY from $10.7M; net loss $0.16 per share vs. net income $0.14 per diluted share.

• February 5, 2025, 6:59 PM ET earnings materiality 0.75 negative item 2.02item 9.01

  Sensus Healthcare Q4 revenue $13.1M, EPS $0.09; record 39 SRT shipments; Q1 sales expected lower

  Q4 2024 revenue $13.1M (+4% YoY); full-year revenue $41.8M (+71% YoY).

• November 18, 2024, 6:59 PM ET earnings materiality 0.80 positive item 2.02item 9.01

  Sensus Q3 revenues double to $8.8M; net income $1.2M vs loss; targets >50 IG-SRT deals by year-end

  Revenue $8.8M (+127% YoY); net income $1.2M ($0.07 diluted EPS) vs net loss $1.5M ($0.09 loss) in Q3 2023.

• November 14, 2024, 6:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  Sensus Healthcare Q3 2024 revenue doubles to $8.8M; net income of $0.07 per diluted share

  Revenue $8.8M (+127% YoY); net income $1.2M vs net loss $1.5M in Q3 2023.

• August 8, 2024, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  Sensus Healthcare Q2 2024 revenue $9.2M (+104% YoY); net income $1.6M

  Revenue $9.2M vs $4.5M in Q2 2023, up 104%; 23 systems shipped (including 3 to Asia) vs 13 last year.

• May 9, 2024, 7:59 PM ET earnings materiality 0.85 positive item 2.02item 9.01 ◈ Earnings Releases

  Sensus Healthcare Q1 revenue $10.7M (up 214% YoY); net income $2.3M vs loss of $1.9M

  Revenue $10.7M, up 214% from $3.4M; shipped 26 systems vs 10 YoY.

Executive changes

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.85 · Median 0.65 · Most common event earnings

5 positive 6 negative 9 neutral

source · SRTS on sec.gov